Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 ФГБОУ ВО «Красноярский государственный медицинский университет им. проф. Ф.В. Войно-Ясенецкого» Минздрава России, Красноярск, Россия; 2 ФГБНУ «Научно-исследовательский институт медицинских проблем Севера» – обособленное подразделение ФГБНУ «Федеральный исследовательский центр КНЦ СО РАН», Красноярск, Россия kev-pulmonolog@mail.ru
Список исп. литературыСкрыть список 1. Agustí A, Celli BR, Criner GJ et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023; 61 (4): 2300239. DOI: 10.1183/13993003.00239-2023 2. Agustí A, Melén E, DeMeo DL et al. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan. Lancet Respir Med. 2022; 10: 512–24. DOI: 10.1016/S2213-2600(21)00555-5 3. Recio Iglesias J, Díez-Manglano J, López García F et al. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document. Int J Chron Obstruct Pulmon Dis. 2020; 15: 1015–37. DOI: 10.2147/COPD.S242009 4. Chetty U, McLean G, Morrison D et al. Chronic obstructive pulmonary disease and comorbidities: a large cross-sectional study in primary care. Br J Gen Pract. 2017; 67 (658): e321-e328. DOI: 10.3399/bjgp17X690605 5. Воронкова О.В., Саприна Т.В., Букреева Е.Б., Зима А.П. Этиопатогенетические параллели и нерешенные вопросы патогенеза коморбидности хронической обструктивной болезни легких и метаболического синдрома (обзор литературы). Ожирение и метаболизм. 2020; 17 (3): 292–8. DOI: 10.14341/omet12378 Voronkova OV, Saprina TV, Bukreeva EB, Zima AP. Etiopathogenetic parallels and unresolved issues of pathogenesis of comorbidity COPD and metabolic syndrome (review). Obesity and metabolism. 2020; 17 (3): 292–8. DOI: 10.14341/omet12378 (in Russian). 6. Zareifopoulos N, Bellou A, Spiropoulou A, Spiropoulos K. Prevalence, Contribution to Disease Burden and Management of Comorbid Depression and Anxiety in Chronic Obstructive Pulmonary Disease: A Narrative Review. J Obstr Pulm Dis. 2019; 16: 406–17. DOI: 10.1080/ 15412555.2019.1679102 7. Yohannes AM, Kaplan A, Hanania NA. Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management. Cleve Clin J Med. 2018; 85 (2 Suppl. 1): S11–S18. DOI: 10.3949/ccjm.85.s1.03 8. Cleutjens FA, Franssen FM, Spruit MA et al. Domain-specific cognitive impairment in patients with COPD and control subjects. Int J Chron Obstruct Pulmon Dis. 2016; 12: 1–11. DOI: 10.2147/COPD.S119633 9. Montserrat-Capdevila J, Godoy P, Marsal JR et al. Overview of the Impact of Depression and Anxiety in Chronic Obstructive Pulmonary Disease. Lung. 2017; 195 (1): 77–85. DOI: 10.1007/s00408-016-9966-0 10. Lecheler L, Richter M, Franzen DP et al. The frequent and underrecognised co-occurrence of acute exacerbated COPD and depression warrants screening: a systematic review. Eur Respir Rev. 2017; 26 (144): 170026. DOI: 10.1183/16000617.0026-2017 11. Vikjord SAA, Brumpton BM, Mai XM et al. The association of anxiety and depression with mortality in a COPD cohort. The HUNT study, Norway. Respir Med. 2020; 171: 106089. DOI: 10.1016/j.rmed.2020. 106089 12. Tselebis A, Pachi A, Ilias I et al. Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatr Dis Treat. 2016; 12: 297–328. DOI: 10.2147/NDT.S 79354 13. Keeratichananont W, Kaenmuang P, Geater SL et al. Prevalence, associated factors, and clinical consequences of metabolic syndrome in chronic obstructive pulmonary disease patients: a 5-year prospective observational study. Ther Adv Respir Dis. 2023; 17: 17534666231167342. DOI: 10.1177/17534666231167342 14. Kiani FZ, Ahmadi A. The Prevalence of Metabolic Syndrome, Scoring, and Comparison in People With and Without COPD: Evidence from Shahrekord PERSIAN Cohort Study. Metab Syndr Relat Disord. 2022; 20 (4): 224–33. DOI: 10.1089/met.2021.0060 15. Ambroselli D, Masciulli F, Romano E et al. New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food. Nutrients. 2023; 15: 640. DOI: 10.3390/nu15030640 16. Cebron Lipovec N, Beijers RJ, van den Borst B et al. The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review. COPD. 2016; 13 (3): 399–406. DOI: 10.3109/ 15412555.2016.1140732 17. Singh D, Agusti A, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: The GOLD science committee report 2019. Eur Respir J. 2019; 53 (5): 1900164. DOI: 10.1183/13993003.00164-2019 18. Консенсус экспертов по междисциплинарному подходу к ведению, диагностике и лечению больных с метаболическим синдромом. Кардиоваскулярная терапия и профилактика. 2013; 12 (6): 41–82. EDN: RSYQYP. Experts’ consensus on the interdisciplinary approach towards the management, diagnostics, and treatment of patients with metabolic syndrome. Cardiovascular Therapy and Prevention. 2013; 12 (6): 41–82. EDN: RSYQYP (in Russian). 19. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Measur. 1977; 1: 385–401. DOI: 10.1177/014662167700100306 20. Laforest L, Roche N, Devouassoux G et al. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study. Respir Med. 2016; 117: 33–9. DOI: 10.1016/j.rmed.2016.05.019 21. Lecheler L, Richter M, Franzen DP et al. The frequent and underrecognised co-occurrence of acute exacerbated COPD and depression warrants screening: a systematic review. Eur Respir Rev. 2017; 26 (144): 170026. DOI: 10.1183/16000617.0026-2017 22. Moorehead NR, Goodie JL, Krantz DS. Prospective Bidirectional Relations Between Depression and Metabolic Health: 30 Year Follow-up from the NHLBI CARDIA Study. medRxiv [Preprint]. 2023: 2023.03.08.23286983. DOI: 10.1101/2023.03.08.23286983 23. Джериева И.С., Волкова Н.И., Рапопорт С.И. Ассоциация между депрессией и метаболическим синдромом. Клиническая медицина. 2015; 93 (1): 62–5. EDN: TIKBBP. Dzherieva IS, Volkova NI, Rapoport SI. Association between depression and metabolic syndrome - a two-way street. Clin Med. 2015; 93 (1): 62–5. EDN: TIKBBP (in Russian). 24. Кочетова Е.В. Выраженность депрессии у больных хронической обструктивной болезнью легких в сочетании с гипертонической болезнью. Медико-фармацевтический журнал Пульс. 2020; 22 (9): 36–41. DOI: 10.26787/nydha-2686-6838-2020-22-9-36-41 Kochetova EV. The severity of depression in patients with chronic obstructive pulmonary disease in combination with essential hypertension. Medical and Pharmaceutical Journal Pulse. 2020; 22 (9): 36–41. DOI: 10.26787/nydha-2686-6838-2020-22-9-36-41 (in Russian). 25. Hayashi Y, Senjyu H, Iguchi A et al. Prevalence of depressive symptoms in Japanese male patients with chronic obstructive pulmonary disease. Psychiatry Clin Neurosci. 2011; 65 (1): 82–8. DOI: 10.1111/j.1440-1819.2010.02171.x 26. Iguchi A, Senjyu H, Hayashi Y et al. Relationship between depression in patients with COPD and the percent of predicted FEV(1), BODE index, and health-related quality of life. Respir Care. 2013; 58 (2): 334–9. DOI: 10.4187/respcare.01844